Scott Alexander’s long-running satire on Bay Area house parties has always blurred fact and fiction, casting the narrator as a bewildered outsider. Two weeks ago the author actually slipped into a “spring gay peptide” gathering in San Francisco, where the buzz wasn’t AI but injectable peptides marketed as cheap Chinese alternatives. The scene felt like a live extension of Alexander’s absurdist sketches for the author.

Guests roamed the loft sipping jello shots from syringes while swapping stories about semaglutide, tirzepatide and the newer “street reta” analogues. At least four founders bragged they were building peptide startups, claiming the compounds could reshape personality, skin and sleep. One quip summed it up: “Ugliness is a choice now,” underscoring the cult‑like devotion to GLP‑1‑based hacks.

The episode illustrates San Francisco’s hyper‑sincere tech culture, where earnest claims about “changing the world” coexist with frivolous bio‑hacking rituals. Visitors from New York often mistake the fervor for satire, yet locals treat peptide stacking as a status signal as real as venture capital. The party’s oddity proves that niche biotech trends can shape social norms faster than any startup pitch.